Literature DB >> 28303323

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

Kristina Dahlem1, Guido Michels2, Carsten Kobe3, Alexander C Bunck4, Henrik Ten Freyhaus2, Roman Pfister2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28303323     DOI： 10.1007/s00392-017-1092-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  8 in total

1.  Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.

Authors:  Andor W J M Glaudemans; Ronald W J van Rheenen; Maarten P van den Berg; Walter Noordzij; Michel Koole; Hans Blokzijl; Rudi A J O Dierckx; Riemer H J A Slart; Bouke P C Hazenberg
Journal:  Amyloid       Date:  2014-01-23       Impact factor: 7.141

2.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

3.  Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Florian Andre; Sebastian Seitz; Evangelos Giannitsis; Henning Steen; Hugo A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2015-02-18       Impact factor: 5.460

4.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

5.  Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.

Authors:  Dania Mohty; Sarah Pradel; Julien Magne; Bahaa Fadel; Cyrille Boulogne; Vincent Petitalot; Safaa Raboukhi; Nicole Darodes; Thibaud Damy; Victor Aboyans; Arnaud Jaccard
Journal:  Clin Res Cardiol       Date:  2016-12-08       Impact factor: 5.460

Review 6.  Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

Authors:  Morie A Gertz; Merrill D Benson; Peter J Dyck; Martha Grogan; Terresa Coelho; Marcia Cruz; John L Berk; Violaine Plante-Bordeneuve; Hartmut H J Schmidt; Giampaolo Merlini
Journal:  J Am Coll Cardiol       Date:  2015-12-01       Impact factor: 24.094

7.  Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Authors:  Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

8.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690
  8 in total
  4 in total

1.  Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Authors:  F Aus dem Siepen; R Bauer; A Voss; S Hein; M Aurich; J Riffel; D Mereles; C Röcken; S J Buss; H A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2017-09-27       Impact factor: 5.460

Review 2.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

3.  When and how do patients with cardiac amyloidosis die?

Authors:  F Escher; M Senoner; J Doerler; M M Zaruba; M Messner; C Mussner-Seeber; M Ebert; C Ensinger; A Mair; A Kroiss; H Ulmer; S Schneiderbauer-Porod; C Ebner; G Poelzl
Journal:  Clin Res Cardiol       Date:  2019-05-27       Impact factor: 5.460

4.  Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis.

Authors:  Anca Florian; Michael Bietenbeck; Grigorios Chatzantonis; Anna Hüsing-Kabar; Hartmut Schmidt; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2020-02-11       Impact factor: 5.460
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.